OSAKA -- Kyoto University scientists have found that correcting a genetic defect that causes muscular dystrophy can alleviate the symptoms of the severest form of this debilitating disease.
Akitsu Hotta and his colleagues used induced pluripotent stem (iPS) cells -- cells reprogrammed to an embryonic state -- to test their hypothesis. While much work remains to turn their discovery into a practical treatment, it does give cause for hope.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.